NCT00102479View on ClinicalTrials.gov

Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2004

Study Completion Date

July 31, 2005

Conditions
SchizophreniaMania
Interventions
DRUG

Aripiprazole

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT00102479 - Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents | Biotech Hunter | Biotech Hunter